Bio-Rad Laboratories, Inc.BIONYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+103.9%
5Y CAGR-14.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+103.9%/yr
vs +41.4%/yr prior
5Y CAGR
-14.9%/yr
Recent acceleration
Acceleration
+62.5pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.74% |
| Q3 2025 | -0.43% |
| Q2 2025 | -0.53% |
| Q1 2025 | 2.35% |
| Q4 2024 | 1.78% |
| Q3 2024 | 2.20% |
| Q2 2024 | -6.82% |
| Q1 2024 | 2.23% |
| Q4 2023 | 2.33% |
| Q3 2023 | -3.19% |
| Q2 2023 | -7.86% |
| Q1 2023 | 6.28% |
| Q4 2022 | 0.56% |
| Q3 2022 | 1.11% |
| Q2 2022 | 6.12% |
| Q1 2022 | -12.25% |
| Q4 2021 | 3.70% |
| Q3 2021 | 1.28% |
| Q2 2021 | -5.50% |
| Q1 2021 | 3.06% |
| Q4 2020 | 10.59% |
| Q3 2020 | 4.70% |
| Q2 2020 | -2.29% |
| Q1 2020 | -9.56% |
| Q4 2019 | 6.22% |
| Q3 2019 | 0.18% |
| Q2 2019 | -3.05% |
| Q1 2019 | -2.33% |
| Q4 2018 | 5.64% |
| Q3 2018 | -4.39% |
| Q2 2018 | 0.62% |
| Q1 2018 | 2.41% |
| Q4 2017 | 3.78% |
| Q3 2017 | -7.63% |
| Q2 2017 | 9.28% |
| Q1 2017 | -11.40% |
| Q4 2016 | 9.22% |
| Q3 2016 | -1.99% |
| Q2 2016 | 8.34% |
| Q1 2016 | -1.78% |